{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:00:40Z","timestamp":1791342040295,"version":"4.3.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000096","name":"Scottish Rite Charitable Foundation of Canada","doi-asserted-by":"publisher","award":["17106"],"award-info":[{"award-number":["17106"]}],"id":[{"id":"10.13039\/501100000096","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["35170"],"award-info":[{"award-number":["35170"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004482","name":"Kuwait University","doi-asserted-by":"publisher","award":["ZM03\/16"],"award-info":[{"award-number":["ZM03\/16"]}],"id":[{"id":"10.13039\/501100004482","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbi.2021.07.016","type":"journal-article","created":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T02:03:50Z","timestamp":1627697030000},"page":"363-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression"],"prefix":"10.1016","volume":"99","author":[{"given":"Mohammed A.","family":"Al-Onaizi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Th\u00e9riault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lecordier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Prefontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Rivest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-6039","authenticated-orcid":false,"given":"Ayman","family":"ElAli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0005","first-page":"1615","article-title":"Regulation of cognitive processing by hippocampal cholinergic tone","volume":"27","author":"Al-Onaizi","year":"2017","journal-title":"Cereb. Cortex"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0010","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3233\/JAD-141389","article-title":"Memory improvement in the abetaPP\/PS1 mouse model of familial Alzheimer's disease induced by carbamylated-erythropoietin is accompanied by modulation of synaptic genes","volume":"45","author":"Armand-Ugon","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0015","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1146\/annurev.immunol.021908.132557","article-title":"Blood monocytes: development, heterogeneity, and relationship with dendritic cells","volume":"27","author":"Auffray","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2021.07.016_b0020","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/157016110793563915","article-title":"Nov). Controversies in hypertension treatment","volume":"8","author":"Banach","year":"2010","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.bbi.2021.07.016_b0025","doi-asserted-by":"crossref","unstructured":"Bateman, R. J., Xiong, C., Benzinger, T. L., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., Holtzman, D. M., Santacruz, A., Buckles, V., Oliver, A., Moulder, K., Aisen, P. S., Ghetti, B., Klunk, W. E., McDade, E., Martins, R. N., Masters, C. L., Mayeux, R., Ringman, J. M., Rossor, M. N., Schofield, P. R., Sperling, R. A., Salloway, S., Morris, J. C., & Dominantly Inherited Alzheimer, N., 2012. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med, 367(9), 795\u2013804. https:\/\/doi.org\/10.1056\/NEJMoa1202753.","DOI":"10.1056\/NEJMoa1202753"},{"key":"10.1016\/j.bbi.2021.07.016_b0030","doi-asserted-by":"crossref","unstructured":"Bengoetxea, X., Rodriguez-Perdigon, M., Ramirez, M.J., 2015. Object recognition test for studying cognitive impairments in animal models of Alzheimer's disease. Front Biosci (Schol Ed), 7, 10\u201329. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25961683.","DOI":"10.2741\/421"},{"issue":"9","key":"10.1016\/j.bbi.2021.07.016_b0035","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1073\/pnas.1214099110","article-title":"Alternative erythropoietin-mediated signaling prevents secondary microvascular thrombosis and inflammation within cutaneous burns","volume":"110","author":"Bohr","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"Pt 4","key":"10.1016\/j.bbi.2021.07.016_b0040","first-page":"1078","article-title":"Apr). Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease","volume":"132","author":"Boissonneault","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.bbi.2021.07.016_b0045","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3389\/fimmu.2014.00523","article-title":"Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia","volume":"5","author":"Bond","year":"2014","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0002-9440(10)63945-4","article-title":"Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice","volume":"158","author":"Bornemann","year":"2001","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.bbi.2021.07.016_b0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000116984","article-title":"Staging of Alzheimer-related cortical destruction","volume":"33","author":"Braak","year":"1993","journal-title":"Eur. Neurol."},{"issue":"41","key":"10.1016\/j.bbi.2021.07.016_b0060","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0406491101","article-title":"Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor","volume":"101","author":"Brines","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"31","key":"10.1016\/j.bbi.2021.07.016_b0065","doi-asserted-by":"crossref","first-page":"10925","DOI":"10.1073\/pnas.0805594105","article-title":"Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin","volume":"105","author":"Brines","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0070","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2119\/molmed.2014.00215","article-title":"ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes","volume":"20","author":"Brines","year":"2015","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0075","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1101\/lm.1650110","article-title":"Object recognition memory and the rodent hippocampus","volume":"17","author":"Broadbent","year":"2010","journal-title":"Learn. Mem."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.016_b0080","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3233\/JAD-180250","article-title":"Association between hippocampal shape, neuroinflammation, and cognitive decline in Alzheimer's Disease","volume":"66","author":"Cabinio","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.bbi.2021.07.016_b0085","doi-asserted-by":"crossref","unstructured":"Chang, R., Al Maghribi, A., Vanderpoel, V., Vasilevko, V., Cribbs, D. H., Boado, R., Pardridge, W. M., Sumbria, R.K., 2020. A brain penetrating bifunctional erythropoietin-transferrin receptor antibody fusion protein for Alzheimer's Disease. Mol. Pharm., 17(1), 360. 10.1021\/acs.molpharmaceut.9b01211.","DOI":"10.1021\/acs.molpharmaceut.9b01211"},{"key":"10.1016\/j.bbi.2021.07.016_b0090","doi-asserted-by":"crossref","unstructured":"Chateauvieux, S., Grigorakaki, C., Morceau, F., Dicato, M., & Diederich, M., 2011. Erythropoietin, erythropoiesis and beyond. Biochem. Pharmacol., 82(10), 1291\u20131303. 10.1016\/j.bcp.2011.06.045.","DOI":"10.1016\/j.bcp.2011.06.045"},{"issue":"33","key":"10.1016\/j.bbi.2021.07.016_b0095","doi-asserted-by":"crossref","first-page":"23818","DOI":"10.1074\/jbc.M701078200","article-title":"Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models","volume":"282","author":"Cheng","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0100","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia function in the central nervous system during health and neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bbi.2021.07.016_b0105","doi-asserted-by":"crossref","unstructured":"Corwin, H.L., Gettinger, A., Fabian, T. C., May, A., Pearl, R.G., Heard, S., An, R., Bowers, P. J., Burton, P., Klausner, M.A., Corwin, M.J., Group, E.P.O.C.C.T. (2007, Sep 6). Efficacy and safety of epoetin alfa in critically ill patients. N. Engl. J. Med., 357(10), 965\u2013976. https:\/\/doi.org\/10.1056\/NEJMoa071533.","DOI":"10.1056\/NEJMoa071533"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0110","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2119\/molmed.2013.00122","article-title":"ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density","volume":"19","author":"Dahan","year":"2013","journal-title":"Mol. Med."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0115","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2021.07.016_b0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbi.2015.07.021","article-title":"Microglia in Alzheimer's disease: a multifaceted relationship","volume":"55","author":"ElAli","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2021.07.016_b0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/2051-5960-1-75","article-title":"Mild chronic cerebral hypoperfusion induces neurovascular dysfunction, triggering peripheral beta-amyloid brain entry and aggregation","volume":"1","author":"ElAli","year":"2013","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.bbi.2021.07.016_b0130","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/npp.2015.279","article-title":"Tissue-plasminogen activator attenuates Alzheimer's disease-related pathology development in APPswe\/PS1 Mice","volume":"41","author":"ElAli","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2021.07.016_b0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pbb.2014.12.011","article-title":"Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease","volume":"130","author":"Esmaeili Tazangi","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Pt 12","key":"10.1016\/j.bbi.2021.07.016_b0140","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1093\/brain\/awv288","article-title":"Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease","volume":"138","author":"Fan","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12974-020-01893-3","article-title":"Muramyl dipeptide-mediated immunomodulation on monocyte subsets exerts therapeutic effects in a mouse model of Alzheimer's disease","volume":"17","author":"Fani Maleki","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.bbi.2021.07.016_b0150","article-title":"Selective immunomodulatory and neuroprotective effects of a NOD2 receptor agonist on mouse models of multiple sclerosis","author":"Fani Maleki","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0155","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/bs8020026","article-title":"Neuroprotective effects of neuroEPO using an in vitro model of stroke","volume":"8","author":"Fernando","year":"2018","journal-title":"Behav. Sci. (Basel)"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1601-183X.2008.00453.x","article-title":"Cognitive and non-cognitive behaviors in an APPswe\/PS1 bigenic model of Alzheimer's disease","volume":"8","author":"Filali","year":"2009","journal-title":"Genes Brain Behav."},{"issue":"S3","key":"10.1016\/j.bbi.2021.07.016_b0165","first-page":"497","article-title":"Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment","volume":"8","author":"Finkel","year":"1996","journal-title":"Int. Psychogeriatr."},{"issue":"12","key":"10.1016\/j.bbi.2021.07.016_b0170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1474-4422(12)70227-2","article-title":"Florbetapir PET analysis of amyloid-beta deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study","volume":"11","author":"Fleisher","year":"2012","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0175","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3233\/JAD-180668","article-title":"NeuroEPO preserves neurons from glutamate-induced excitotoxicity","volume":"65","author":"Garzon","year":"2018","journal-title":"J. Alzheimers Dis."},{"issue":"1\u20132","key":"10.1016\/j.bbi.2021.07.016_b0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2003.12.037","article-title":"Erythropoietin and the nervous system","volume":"1000","author":"Genc","year":"2004","journal-title":"Brain Res."},{"issue":"6","key":"10.1016\/j.bbi.2021.07.016_b0185","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri3671","article-title":"Monocytes and macrophages: developmental pathways and tissue homeostasis","volume":"14","author":"Ginhoux","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0190","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1471-4159.2007.04988.x","article-title":"Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells","volume":"104","author":"Gonzalez-Velasquez","year":"2008","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.2001.7754","article-title":"Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse","volume":"173","author":"Gordon","year":"2002","journal-title":"Exp. Neurol."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0200","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbi.2021.07.016_b0205","doi-asserted-by":"crossref","unstructured":"Hanna, R.N., Carlin, L.M., Hubbeling, H.G., Nackiewicz, D., Green, A.M., Punt, J.A., Geissmann, F., Hedrick, C.C., 2011. The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol., 12(8), 778\u2013785. https:\/\/doi.org\/10.1038\/ni.2063.","DOI":"10.1038\/ni.2063"},{"key":"10.1016\/j.bbi.2021.07.016_b0210","doi-asserted-by":"crossref","unstructured":"Hardy, J., Selkoe, D.J., 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science, 297(5580), 353\u2013356. https:\/\/doi.org\/10.1126\/science.1072994.","DOI":"10.1126\/science.1072994"},{"key":"10.1016\/j.bbi.2021.07.016_b0215","doi-asserted-by":"crossref","unstructured":"Hassouna, I., Ott, C., Wustefeld, L., Offen, N., Neher, R. A., Mitkovski, M., Winkler, D., Sperling, S., Fries, L., Goebbels, S., Vreja, I. C., Hagemeyer, N., Dittrich, M., Rossetti, M. F., Krohnert, K., Hannke, K., Boretius, S., Zeug, A., Hoschen, C., Dandekar, T., Dere, E., Neher, E., Rizzoli, S. O., Nave, K. A., Siren, A.L., Ehrenreich, H., 2016. Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus. Mol. Psychiatry, 21(12), 1752\u20131767. https:\/\/doi.org\/10.1038\/mp.2015.212.","DOI":"10.1038\/mp.2015.212"},{"key":"10.1016\/j.bbi.2021.07.016_b0220","doi-asserted-by":"crossref","unstructured":"Heneka, M.T., Carson, M. J., El Khoury, J., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., Herrup, K., Frautschy, S. A., Finsen, B., Brown, G. C., Verkhratsky, A., Yamanaka, K., Koistinaho, J., Latz, E., Halle, A., Petzold, G. C., Town, T., Morgan, D., Shinohara, M. L., Perry, V. H., Holmes, C., Bazan, N. G., Brooks, D. J., Hunot, S., Joseph, B., Deigendesch, N., Garaschuk, O., Boddeke, E., Dinarello, C. A., Breitner, J. C., Cole, G. M., Golenbock, D. T., Kummer, M.P., 2015. Neuroinflammation in Alzheimer's disease. Lancet Neurol, 14(4), 388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5.","DOI":"10.1016\/S1474-4422(15)70016-5"},{"issue":"33","key":"10.1016\/j.bbi.2021.07.016_b0225","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.0616-08.2008","article-title":"Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice","volume":"28","author":"Hickman","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbi.2021.07.016_b0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exger.2015.03.002","article-title":"Migration of blood cells to beta-amyloid plaques in Alzheimer's disease","volume":"65","author":"Hohsfield","year":"2015","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nm0198-097","article-title":"Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes","volume":"4","author":"Holcomb","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2021.07.016_b0240","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuroscience.2018.08.001","article-title":"CEPO-Fc (an EPO derivative) protects hippocampus against A\u03b2-induced memory deterioration: a behavioral and molecular study in a rat model of A\u03b2 toxicity","volume":"388","author":"Hooshmandi","year":"2018","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.bbi.2021.07.016_b0245","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1111\/jcmm.13608","article-title":"Non-erythropoietic erythropoietin-derived peptide protects mice from systemic lupus erythematosus","volume":"22","author":"Huang","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol."},{"issue":"12","key":"10.1016\/j.bbi.2021.07.016_b0255","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3390\/ph13120424","article-title":"Current evidence on the protective effects of recombinant human erythropoietin and its molecular variants against pathological hallmarks of Alzheimer's disease","volume":"13","author":"Jarero-Basulto","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"10.1016\/j.bbi.2021.07.016_b0260","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1007\/s12035-019-1539-9","article-title":"Canonical Wnt pathway maintains blood-brain barrier integrity upon ischemic stroke and its activation ameliorates tissue plasminogen activator therapy","volume":"56","author":"Jean LeBlanc","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.bbi.2021.07.016_b0265","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000356193","article-title":"Physiology and pharmacology of erythropoietin","volume":"40","author":"Jelkmann","year":"2013","journal-title":"Transfus Med. Hemother."},{"issue":"5618","key":"10.1016\/j.bbi.2021.07.016_b0270","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"issue":"Pt 8","key":"10.1016\/j.bbi.2021.07.016_b0275","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/brain\/awv150","article-title":"Therapeutic effects of glatiramer acetate and grafted CD115(+) monocytes in a mouse model of Alzheimer's disease","volume":"138","author":"Koronyo","year":"2015","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0280","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1471-4159.2011.07534.x","article-title":"Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models","volume":"120","author":"Lee","year":"2012","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.016_b0285","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/156720206778018758","article-title":"Microglial integrity is maintained by erythropoietin through integration of Akt and its substrates of glycogen synthase kinase-3beta, beta-catenin, and nuclear factor-kappaB","volume":"3","author":"Li","year":"2006","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.bbi.2021.07.016_b0290","doi-asserted-by":"crossref","unstructured":"Li, C., Shi, J., Wang, B., Li, J., Jia, H., 2019. CB2 cannabinoid receptor agonist ameliorates novel object recognition but not spatial memory in transgenic APP\/PS1 mice. Neurosci Lett, 707, 134286. https:\/\/doi.org\/10.1016\/j.neulet.2019.134286.","DOI":"10.1016\/j.neulet.2019.134286"},{"key":"10.1016\/j.bbi.2021.07.016_b0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.brainres.2015.05.031","article-title":"Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid beta42 in mice","volume":"1618","author":"Li","year":"2015","journal-title":"Brain Res."},{"issue":"7638","key":"10.1016\/j.bbi.2021.07.016_b0300","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2021.07.016_b0305","doi-asserted-by":"crossref","unstructured":"Liu, Y., Luo, B., Han, F., Li, X., Xiong, J., Jiang, M., Yang, X., Wu, Y., & Zhang, Z., 2014. Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection. PLoS One, 9(3), e90942. https:\/\/doi.org\/10.1371\/journal.pone.0090942.","DOI":"10.1371\/journal.pone.0090942"},{"key":"10.1016\/j.bbi.2021.07.016_b0310","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-804766-8.00009-1","article-title":"Epidemiology of aging and associated cognitive disorders: prevalence and incidence of Alzheimer's disease and other dementias","volume":"167","author":"Lopez","year":"2019","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.bbi.2021.07.016_b0315","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/neu.2005.22.1011","article-title":"Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury","volume":"22","author":"Lu","year":"2005","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0320","doi-asserted-by":"crossref","first-page":"533","DOI":"10.5114\/aoms.2010.14464","article-title":"Renal vascular response to angiotensin II inhibition in intensive antihypertensive treatment of essential hypertension","volume":"6","author":"Lubas","year":"2010","journal-title":"Arch. Med. Sci."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.016_b0325","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2174\/156720208784310231","article-title":"Erythropoietin and oxidative stress","volume":"5","author":"Maiese","year":"2008","journal-title":"Curr. Neurovasc. Res."},{"issue":"9","key":"10.1016\/j.bbi.2021.07.016_b0335","doi-asserted-by":"crossref","first-page":"11102","DOI":"10.3390\/ijms130911102","article-title":"Erythropoietin: new directions for the nervous system","volume":"13","author":"Maiese","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.bbi.2021.07.016_b0340","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/glia.20973","article-title":"Jun). The role and therapeutic potential of monocytic cells in Alzheimer's disease","volume":"58","author":"Malm","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.bbi.2021.07.016_b0345","doi-asserted-by":"crossref","unstructured":"Maurice, T., Mustafa, M. H., Desrumaux, C., Keller, E., Naert, G., de la, C. G.-B. M., Rodriguez Cruz, Y., & Garcia Rodriguez, J.C., 2013. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Abeta(2)(5)(-)(3)(5) non-transgenic mouse model of Alzheimer's disease. J. Psychopharmacol., 27(11), 1044\u20131057. https:\/\/doi.org\/10.1177\/0269881113494939.","DOI":"10.1177\/0269881113494939"},{"key":"10.1016\/j.bbi.2021.07.016_b0350","doi-asserted-by":"crossref","unstructured":"Mc Donald, J. M., Savva, G. M., Brayne, C., Welzel, A. T., Forster, G., Shankar, G. M., Selkoe, D. J., Ince, P. G., Walsh, D. M., Medical Research Council Cognitive, F., Ageing, S., 2010. The presence of sodium dodecyl sulphate-stable Abeta dimers is strongly associated with Alzheimer-type dementia. Brain, 133(Pt 5), 1328\u20131341. https:\/\/doi.org\/10.1093\/brain\/awq065.","DOI":"10.1093\/brain\/awq065"},{"issue":"11","key":"10.1016\/j.bbi.2021.07.016_b0355","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.2337\/db11-0026","article-title":"Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy","volume":"60","author":"McVicar","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.bbi.2021.07.016_b0360","doi-asserted-by":"crossref","first-page":"104881","DOI":"10.1016\/j.neuint.2020.104881","article-title":"Dickkopf-related protein-1 inhibition attenuates amyloid-beta pathology associated to Alzheimer's disease","volume":"141","author":"Menet","year":"2020","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.bbi.2021.07.016_b0365","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.celrep.2013.10.010","article-title":"Real-time in vivo imaging reveals the ability of monocytes to clear vascular amyloid beta","volume":"5","author":"Michaud","year":"2013","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0370","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.biopsych.2014.12.013","article-title":"Effects of erythropoietin on hippocampal volume and memory in mood disorders","volume":"78","author":"Miskowiak","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2021.07.016_b0375","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fncel.2012.00051","article-title":"Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)\/PS1 mice","volume":"6","author":"Naert","year":"2012","journal-title":"Front. Cell Neurosci."},{"issue":"5","key":"10.1016\/j.bbi.2021.07.016_b0380","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jmcb\/mjt028","article-title":"A deficiency in CCR2+ monocytes: the hidden side of Alzheimer's disease","volume":"5","author":"Naert","year":"2013","journal-title":"J. Mol. Cell Biol."},{"issue":"11","key":"10.1016\/j.bbi.2021.07.016_b0385","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1177\/1535370214523703","article-title":"Erythropoietin: powerful protection of ischemic and post-ischemic brain","volume":"239","author":"Nguyen","year":"2014","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0390","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.critrevonc.2007.03.001","article-title":"Role of erythropoietin in the brain","volume":"64","author":"Noguchi","year":"2007","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0395","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1574-695X.2011.00801.x","article-title":"The erythropoietin analogue ARA290 modulates the innate immune response and reduces Escherichia coli invasion into urothelial cells","volume":"62","author":"Polg\u00e1rov\u00e1","year":"2011","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0400","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pathophys.2012.02.005","article-title":"Erythropoietin neuroprotection with traumatic brain injury","volume":"20","author":"Ponce","year":"2013","journal-title":"Pathophysiology"},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0405","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0166-4328(82)90039-0","article-title":"The septo-hippocampal system and cognitive mapping","volume":"5","author":"Rawlins","year":"1982","journal-title":"Behav. Brain Res."},{"issue":"11","key":"10.1016\/j.bbi.2021.07.016_b0410","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","article-title":"Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins","volume":"13","author":"Ray","year":"2007","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.bbi.2021.07.016_b0415","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nn910","article-title":"Spatial memory dissociations in mice lacking GluR1","volume":"5","author":"Reisel","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbi.2021.07.016_b0420","doi-asserted-by":"crossref","unstructured":"Robertson, C. S., Hannay, H. J., Yamal, J. M., Gopinath, S., Goodman, J. C., Tilley, B. C., Epo Severe, T. B. I. T. I., Baldwin, A., Rivera Lara, L., Saucedo-Crespo, H., Ahmed, O., Sadasivan, S., Ponce, L., Cruz-Navarro, J., Shahin, H., Aisiku, I. P., Doshi, P., Valadka, A., Neipert, L., Waguspack, J. M., Rubin, M. L., Benoit, J. S., Swank, P., 2014. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA, 312(1), 36\u201347. https:\/\/doi.org\/10.1001\/jama.2014.6490.","DOI":"10.1001\/jama.2014.6490"},{"issue":"9","key":"10.1016\/j.bbi.2021.07.016_b0425","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/neu.2012.2431","article-title":"Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide","volume":"30","author":"Robertson","year":"2013","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bbi.2021.07.016_b0430","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1100\/tsw.2010.215","article-title":"Treatment with nasal neuro-EPO improves the neurological, cognitive, and histological state in a gerbil model of focal ischemia","volume":"10","author":"Rodriguez Cruz","year":"2010","journal-title":"Sci. World J."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0435","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-160500","article-title":"An intranasal formulation of erythropoietin (Neuro-EPO) prevents memory deficits and amyloid toxicity in the APPSwe transgenic mouse model of Alzheimer's disease","volume":"55","author":"Rodriguez Cruz","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0440","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-131160","article-title":"A complex proinflammatory role for peripheral monocytes in Alzheimer's disease","volume":"38","author":"Saresella","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0445","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bpa.2010.10.005","article-title":"Erythropoietin as neuroprotective and neuroregenerative treatment strategy: comprehensive overview of 12 years of preclinical and clinical research","volume":"24","author":"Sargin","year":"2010","journal-title":"Best Pract. Res. Clin. Anaesthesiol."},{"key":"10.1016\/j.bbi.2021.07.016_b0450","doi-asserted-by":"crossref","unstructured":"Selkoe, D.J., 2011. Alzheimer's disease. Cold Spring Harb. Perspect. Biol., 3(7). https:\/\/doi.org\/10.1101\/cshperspect.a004457.","DOI":"10.1101\/cshperspect.a004457"},{"key":"10.1016\/j.bbi.2021.07.016_b0455","doi-asserted-by":"crossref","unstructured":"Shang, Y. C., Chong, Z. Z., Wang, S., Maiese, K., 2012. Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K\/mTOR pathway, Bad, and Bcl-xL. Aging (Albany NY), 4(3), 187\u2013201. https:\/\/doi.org\/10.18632\/aging.100440.","DOI":"10.18632\/aging.100440"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0460","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.nurt.2008.10.041","article-title":"Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system","volume":"6","author":"Siren","year":"2009","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.bbi.2021.07.016_b0465","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.arcmed.2012.11.003","article-title":"Epidemiology of dementias and Alzheimer's disease","volume":"43","author":"Sosa-Ortiz","year":"2012","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bbi.2021.07.016_b0470","doi-asserted-by":"crossref","unstructured":"Soulet, D., Par\u00e9, A., Coste, J., Lacroix, S., 2013. Automated filtering of intrinsic movement artifacts during two-photon intravital microscopy. PLoS One, 8(1), e53942. https:\/\/doi.org\/10.1371\/journal.pone.0053942.","DOI":"10.1371\/journal.pone.0053942"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0475","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12017-019-08524-y","article-title":"The promises and challenges of erythropoietin for treatment of Alzheimer's disease","volume":"21","author":"Sun","year":"2019","journal-title":"Neuromolecular Med."},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0480","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13195-015-0125-2","article-title":"The dynamics of monocytes and microglia in Alzheimer's disease","volume":"7","author":"Th\u00e9riault","year":"2015","journal-title":"Alzheimers Res. Ther."},{"issue":"42","key":"10.1016\/j.bbi.2021.07.016_b0485","doi-asserted-by":"crossref","first-page":"67808","DOI":"10.18632\/oncotarget.12179","article-title":"High fat diet exacerbates Alzheimer's disease-related pathology in APPswe\/PS1 mice","volume":"7","author":"Th\u00e9riault","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbi.2021.07.016_b0490","doi-asserted-by":"crossref","unstructured":"Th\u00e9riault, P., Le Behot, A., ElAli, A., Rivest, S., 2016. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner. Oncotarget, 7(24), 35552\u201335561. https:\/\/doi.org\/10.18632\/oncotarget.9652.","DOI":"10.18632\/oncotarget.9652"},{"issue":"6","key":"10.1016\/j.bbi.2021.07.016_b0495","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.20101","article-title":"Progressive age-related development of Alzheimer-like pathology in APP\/PS1 mice","volume":"55","author":"Trinchese","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbi.2021.07.016_b0500","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnbeh.2019.00092","article-title":"Impaired reversal learning in APPPS1-21 mice in the touchscreen visual discrimination task","volume":"13","author":"Van den Broeck","year":"2019","journal-title":"Front Behav Neurosci"},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0505","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/13543784.2014.892072","article-title":"ARA 290 for treatment of small fiber neuropathy in sarcoidosis","volume":"23","author":"van Velzen","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bbi.2021.07.016_b0510","doi-asserted-by":"crossref","unstructured":"Villemagne, V. L., Burnham, S., Bourgeat, P., Brown, B., Ellis, K. A., Salvado, O., Szoeke, C., Macaulay, S. L., Martins, R., Maruff, P., Ames, D., Rowe, C. C., Masters, C.L.; AAustralian Imaging Biomarkers and Lifestyle (AIBL) Research Group. (2013, Apr). Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol., 12(4), 357-367. https:\/\/doi.org\/10.1016\/S1474-4422(13)70044-9.","DOI":"10.1016\/S1474-4422(13)70044-9"},{"issue":"2","key":"10.1016\/j.bbi.2021.07.016_b0515","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1471-4159.2005.03033.x","article-title":"Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor","volume":"93","author":"Viviani","year":"2005","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbi.2021.07.016_b0520","doi-asserted-by":"crossref","unstructured":"Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., Cella, M., Grutzendler, J., DeMattos, R. B., Cirrito, J. R., Holtzman, D. M., Colonna, M., 2016. TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques. J. Exp. Med., 213(5), 667\u2013675. https:\/\/doi.org\/10.1084\/jem.20151948.","DOI":"10.1084\/jem.20151948"},{"issue":"10","key":"10.1016\/j.bbi.2021.07.016_b0525","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbi.2021.07.016_b0530","doi-asserted-by":"crossref","unstructured":"Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., Sheng, M., 2016. TREM2 Binds to Apolipoproteins, Including APOE and CLU\/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia. Neuron, 91(2), 328\u2013340. https:\/\/doi.org\/10.1016\/j.neuron.2016.06.015.","DOI":"10.1016\/j.neuron.2016.06.015"},{"issue":"1","key":"10.1016\/j.bbi.2021.07.016_b0535","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bbi.2021.07.016_b0540","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3233\/JAD-2012-120151","article-title":"Novel object recognition as a facile behavior test for evaluating drug effects in AbetaPP\/PS1 Alzheimer's disease mouse model","volume":"31","author":"Zhang","year":"2012","journal-title":"J. Alzheimers Dis."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121002804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159121002804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:19:01Z","timestamp":1760170741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159121002804"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":108,"alternative-id":["S0889159121002804"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2021.07.016","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2021.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}